Cargando…
Importance of competing risks in the analysis of anti-epileptic drug failure
BACKGROUND: Retention time (time to treatment failure) is a commonly used outcome in antiepileptic drug (AED) studies. METHODS: Two datasets are used to demonstrate the issues in a competing risks analysis of AEDs. First, data collection and follow-up considerations are discussed with reference to i...
Autores principales: | Williamson, Paula R, Smith, Catrin Tudur, Sander, Josemir W, Marson, Anthony G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1853111/ https://www.ncbi.nlm.nih.gov/pubmed/17394663 http://dx.doi.org/10.1186/1745-6215-8-12 |
Ejemplares similares
-
Anti-epileptic drug harms: issues for meta-analysis
por: Smith, Catrin Tudur, et al.
Publicado: (2011) -
Treatment outcome after failure of a first antiepileptic drug
por: Bonnett, Laura J., et al.
Publicado: (2014) -
Time to 12-month remission and treatment failure for generalised and unclassified epilepsy
por: Bonnett, Laura J, et al.
Publicado: (2014) -
Multiple treatment comparisons in epilepsy monotherapy trials
por: Tudur Smith, Catrin, et al.
Publicado: (2007) -
External Validation of a Prognostic Model for Seizure Recurrence Following a First Unprovoked Seizure and Implications for Driving
por: Bonnett, Laura Jayne, et al.
Publicado: (2014)